Last reviewed · How we verify
Zoledronic acid IV
Zoledronic acid IV is a Small molecule drug developed by National Taiwan University Hospital. It is currently FDA-approved.
Zoledronic acid IV is a small molecule inhibitor of farnesyl diphosphate synthase, a class of drugs known as INHIBITORS. It has been studied for various conditions, including Multiple Myeloma, Breast Cancer, Metastatic Bone Disease, Postmenopausal Osteoporosis, and Postmenopausal Osteopenia.
At a glance
| Generic name | Zoledronic acid IV |
|---|---|
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia (PHASE1, PHASE2)
- Romosozumab Use to Build Skeletal Integrity (PHASE4)
- The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation (PHASE4)
- Preserving Geriatric Muscle With an Osteoporosis Medication (PHASE4)
- Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL) (PHASE4)
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (PHASE1)
- ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers (PHASE1)
- Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zoledronic acid IV CI brief — competitive landscape report
- Zoledronic acid IV updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI
Frequently asked questions about Zoledronic acid IV
What is Zoledronic acid IV?
Who makes Zoledronic acid IV?
What development phase is Zoledronic acid IV in?
Related
- Manufacturer: National Taiwan University Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing